Please use this identifier to cite or link to this item: https://doi.org/10.1186/s13063-018-2559-x
Title: Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial
Authors: Jafar, T.H 
Tan, N.C 
Allen, J.C 
Finkelstein, E.A 
Goh, P 
Moey, P
Quah, J.H.M 
Hwang, S.W 
Bahadin, J 
Thiagarajah, A.G 
Chan, J
Kang, G
Koong, A 
Keywords: angiotensin receptor antagonist
calcium channel blocking agent
dipeptidyl carboxypeptidase inhibitor
diuretic agent
hydroxymethylglutaryl coenzyme A reductase inhibitor
thiazide diuretic agent
adult
Article
cardiovascular disease
controlled study
cost effectiveness analysis
disability-adjusted life year
drug cost
drug dose increase
drug dose titration
follow up
Framingham risk score
human
hypertension
medication compliance
motivation
multicenter study
multicenter study (topic)
patient compliance
pilot study
primary medical care
quality adjusted life year
randomized controlled trial
randomized controlled trial (topic)
Singapore
systolic blood pressure
cost benefit analysis
counseling
hypertension
outcome assessment
risk factor
sample size
Adult
Cost-Benefit Analysis
Counseling
Humans
Hypertension
Motivation
Outcome Assessment (Health Care)
Risk Factors
Sample Size
Issue Date: 2018
Citation: Jafar, T.H, Tan, N.C, Allen, J.C, Finkelstein, E.A, Goh, P, Moey, P, Quah, J.H.M, Hwang, S.W, Bahadin, J, Thiagarajah, A.G, Chan, J, Kang, G, Koong, A (2018). Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial. Trials 19 (1) : 180. ScholarBank@NUS Repository. https://doi.org/10.1186/s13063-018-2559-x
Rights: Attribution 4.0 International
Abstract: Background: Hypertension is a serious public health problem in Singapore and is associated with significant morbidity and mortality from cardiovascular disease (CVD) with considerable implications for health-care resources. The goal of the trial is to compare a multicomponent intervention (MCI) to usual care to evaluate the effectiveness and cost-effectiveness of the MCI for lowering blood pressure (BP) among adults with uncontrolled hypertension in Singapore primary-care clinics. Methods/design: The study is a cluster randomized trial in eight polyclinics in Singapore: four deliver a structured MCI and four deliver usual care. The components of the MCI are: (1) an algorithm-driven antihypertensive treatment for all hypertensive individuals using single-pill combination (SPC) and lipid-lowering medication for high-risk hypertensive individuals, (2) a motivational conversation for high-risk hypertensive individuals, (3) telephone-based follow-ups of all hypertensive individuals by polyclinic nurses, and (4) discounts on SPC antihypertensive medications. The trial will be conducted with 1000 individuals aged ?40 years with uncontrolled hypertension (systolic BP ?140 mmHg or diastolic BP ?90 mmHg, based on the mean of the last two of three measurements) in eight polyclinics in Singapore. The primary outcome is change in systolic BP from baseline to follow-up at 24 months post-randomization. The incremental cost of MCI per CVD disability adjusted life years (DALY) averted and quality adjusted life years (QALY) saved will be computed. Discussion: The demonstration of an effective and cost-effective hypertension control program that is implementable in busy polyclinics would provide compelling evidence for upscaling the program across all primary-care centers in Singapore, and possibly other regional countries with a similar health-care structure. © 2018 The Author(s).
Source Title: Trials
URI: https://scholarbank.nus.edu.sg/handle/10635/178099
ISSN: 17456215
DOI: 10.1186/s13063-018-2559-x
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s13063-018-2559-x.pdf495.92 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons